A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...

An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Semaglutide (known by its brandname Ozempic) has gained widespread attention for its weight loss benefits, but is officially ...

A team of researchers led by a team at Jiangnan University in China have shown they can "orchestrate the secretion of ...

Researchers from the Washington University School of Medicine looked at the health outcomes among more than two million people taking the popular weight-loss medications.

Spread This NewsCity Press Globally, people wanting to lose weight are turning to Ozempic, the so-called miracle drug ...

Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.

Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis ...